Biomedical Journal

Biomedical Journal

Volume 44, Issue 1, February 2021, Pages 1-6
Biomedical Journal

Highlights
Level up for culture models - How 3D cell culture models benefit SARS-CoV-2 research

https://doi.org/10.1016/j.bj.2021.02.001Get rights and content
Under a Creative Commons license
open access

Abstract

Welcome to a new decade and a new issue of the Biomedical Journal - casting a sorrowful look onto a year that will go down in history as a tombstone etched by the COVID-19 pandemic, but also a hopeful glance into the future, now that multiple vaccination programs against the SARS-CoV-2 virus have started. This issue is dedicated to the continuous effort by researchers all around the globe to understand and counter the pathogen, as well as to be better prepared for future threats. Therefore, we learn about the advantages of complex 3D cell culture models for studying host–virus interactions, and the disease course of COVID-19 in children. Moreover, we discover how neutralising monoclonal antibodies and peptide-based vaccines against SARS-CoV-2 are developed, and the therapeutic potentials of lopinavir/ritonavir, mesenchymal stem cells, as well as plant and algae extracts. Finally, we ponder over the lessons to be learnt from SARS-CoV and MERS, and hear about differences between nucleotide-based SARS-CoV-2 detection methods.

Keywords

SARS-CoV-2
COVID-19
3D cell culture models
Synthetic peptide-based vaccines
Neutralising monoclonal antibodies

Cited by (0)

Peer review under responsibility of Chang Gung University.